These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37542830)

  • 1. Benfluorex metabolism complemented by electrochemistry-mass spectrometry.
    Göldner V; Karst U
    J Pharm Biomed Anal; 2023 Oct; 235():115626. PubMed ID: 37542830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fenfluramine-like cardiovascular side-effects of benfluorex.
    Boutet K; Frachon I; Jobic Y; Gut-Gobert C; Leroyer C; Carlhant-Kowalski D; Sitbon O; Simonneau G; Humbert M
    Eur Respir J; 2009 Mar; 33(3):684-8. PubMed ID: 19251806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse effects of benfluorex on heart valves and pulmonary circulation.
    Szymanski C; Andréjak M; Peltier M; Maréchaux S; Tribouilloy C
    Pharmacoepidemiol Drug Saf; 2014 Jul; 23(7):679-86. PubMed ID: 24817577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatal postoperative systemic pulmonary hypertension in benfluorex-induced valvular heart disease surgery: A case report.
    Baufreton C; Bruneval P; Rousselet MC; Ennezat PV; Fouquet O; Giraud R; Banfi C
    Medicine (Baltimore); 2017 Jan; 96(2):e4985. PubMed ID: 28079786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Benfluorex and valvular heart disease].
    Tribouilloy C; Jeu A; Maréchaux S; Jobic Y; Rusinaru D; Andréjak M
    Presse Med; 2011 Nov; 40(11):1008-16. PubMed ID: 21981882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Echocardiographic evidence for valvular toxicity of benfluorex: a double-blind randomised trial in patients with type 2 diabetes mellitus.
    Derumeaux G; Ernande L; Serusclat A; Servan E; Bruckert E; Rousset H; Senn S; Van Gaal L; Picandet B; Gavini F; Moulin P;
    PLoS One; 2012; 7(6):e38273. PubMed ID: 22723853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitral and aortic valvular disease associated with benfluorex use.
    Etienne Y; Jobic Y; Frachon I; Fatemi M; Castellant P; Quintin-Roué I
    J Heart Valve Dis; 2011 May; 20(3):348-50. PubMed ID: 21714428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications.
    Rothman RB; Baumann MH; Savage JE; Rauser L; McBride A; Hufeisen SJ; Roth BL
    Circulation; 2000 Dec; 102(23):2836-41. PubMed ID: 11104741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased risk of left heart valve regurgitation associated with benfluorex use in patients with diabetes mellitus: a multicenter study.
    Tribouilloy C; Rusinaru D; Maréchaux S; Jeu A; Ederhy S; Donal E; Réant P; Arnalsteen E; Boulanger J; Ennezat PV; Garban T; Jobic Y
    Circulation; 2012 Dec; 126(24):2852-8. PubMed ID: 23143159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Letter on the article: "benfluorex and valvular heart disease"].
    Jobic Y; Etienne Y; Tribouilloy C; Bruneval P; Frachon I
    Presse Med; 2012 Mar; 41(3 Pt 1):326-7. PubMed ID: 22317843
    [No Abstract]   [Full Text] [Related]  

  • 11. Restrictive organic mitral regurgitation associated with benfluorex therapy.
    Tribouilloy C; Rusinaru D; Henon P; Tribouilloy L; Leleu F; Andréjak M; Sevestre H; Peltier M; Caus T
    Eur J Echocardiogr; 2010 Aug; 11(7):614-21. PubMed ID: 20237052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The fenfluramine metabolite (+)-norfenfluramine is vasoactive.
    Ni W; Li MW; Thakali K; Fink GD; Watts SW
    J Pharmacol Exp Ther; 2004 May; 309(2):845-52. PubMed ID: 14752059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of d- and l-norfenfluramine following their administration as individual enantiomers in rats.
    Erenburg N; Hamed R; Shaul C; Barasch D; Perucca E; Bialer M
    Epilepsia; 2024 Feb; 65(2):e14-e19. PubMed ID: 38041575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Six-month efficacy of benfluorex vs. placebo or metformin in diet-failed type 2 diabetic patients.
    Del Prato S; Erkelens DW; Leutenegger M
    Acta Diabetol; 2003 Mar; 40(1):20-7. PubMed ID: 12682825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valvular heart disease associated with benfluorex therapy: high prevalence in patients with unexplained restrictive valvular heart disease.
    Boudes A; Lavoute C; Avierinos JF; Le Dolley Y; Villacampa C; Salem A; Loundou AD; Michel N; Renard S; Habib G
    Eur J Echocardiogr; 2011 Sep; 12(9):688-95. PubMed ID: 21810827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimate of deaths due to valvular insufficiency attributable to the use of benfluorex in France.
    Fournier A; Zureik M
    Pharmacoepidemiol Drug Saf; 2012 Apr; 21(4):343-51. PubMed ID: 22318872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible role of valvular serotonin 5-HT(2B) receptors in the cardiopathy associated with fenfluramine.
    Fitzgerald LW; Burn TC; Brown BS; Patterson JP; Corjay MH; Valentine PA; Sun JH; Link JR; Abbaszade I; Hollis JM; Largent BL; Hartig PR; Hollis GF; Meunier PC; Robichaud AJ; Robertson DW
    Mol Pharmacol; 2000 Jan; 57(1):75-81. PubMed ID: 10617681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The measurement of d-fenfluramine and its metabolite, d-norfenfluramine in plasma and urine with an application of the method to pharmacokinetic studies.
    Richards RP; Gordon BH; Ings RM; Campbell DB; King LJ
    Xenobiotica; 1989 May; 19(5):547-53. PubMed ID: 2750211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of the anorectic agent, d-fenfluramine, and its primary metabolite, d-norfenfluramine, on intact human platelet serotonin uptake and efflux.
    Johnson GJ; Leis LA; Dunlop PC; Weir EK
    J Thromb Haemost; 2003 Dec; 1(12):2663-8. PubMed ID: 14675103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of benfluorex in combination with sulfonylurea in type 2 diabetic patients: an 18-week, randomized, double-blind study.
    Moulin P; Andre M; Alawi H; dos Santos LC; Khalid AK; Koev D; Moore R; Serban V; Picandet B; Francillard M
    Diabetes Care; 2006 Mar; 29(3):515-20. PubMed ID: 16505498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.